AtonRa Partners’s Transmedics TMDX Stock Holding History

AtonRa Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$883K	Sell	11,193 -1,094	-9%	-$66K	1.76%	5
2023 Q3	$673K	Sell	12,287 -179	-1%	-$12.9K	1.41%	10
2023 Q2	$1.05M	Sell	12,466 -2,710	-18%	-$207K	1.62%	13
2023 Q1	$1.15M	Sell	15,176 -2,169	-13%	-$150K	1.68%	8
2022 Q4	$1.07M	Sell	17,345 -3,191	-16%	-$170K	1.36%	16
2022 Q3	$857K	Buy	20,536 +2,268	+12%	+$98.6K	0.84%	48
2022 Q2	$575K	Buy	+18,268	New	+$487K	0.53%	92

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AtonRa Partners's TMDX Position: Q4 2023 in Review

AtonRa Partners reduced its Transmedics (TMDX) stake by 8.9% in Q4 2023, selling an estimated $66K and leaving 11,193 shares worth $883K. The position accounts for 1.76% of the portfolio, ranked #5.

AtonRa Partners first reported a position in TMDX in Q2 2022 and has held it in 7 quarters since. The position peaked at $1.15M in Q1 2023. 248 funds tracked by Wall St. Rank hold TMDX as of Q4 2023.

AtonRa Partners held 11,193 shares of Transmedics worth $883K as of Q4 2023.
AtonRa Partners sold 1,094 Transmedics shares in Q4 2023, an estimated $66K.
Transmedics made up 1.76% of AtonRa Partners's portfolio in Q4 2023, its #5 holding.
AtonRa Partners first reported a position in Transmedics in Q2 2022 and has held it in 7 quarters since.
AtonRa Partners's Transmedics position peaked at $1.15M in Q1 2023.
248 funds tracked by Wall St. Rank held Transmedics as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.